{"name":"TearClear Corp","slug":"tearclear-corp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQbk91SWw5cmEtMzhiRXhJNmRsVnpBaWhfcXg0T0h5Szh4Tm1zSGk0V1h1emxUcVRmaVgyczdpM1ZXXzJFYVBvWXRuNGpXckd1NjJzWmU0ZVFNMmpJSFl6dTFDR0I3Zzk0VURWZmo0bGl1Zl9hbHhOY1k3elhSNXlXM09HeDlMNk5mSFlZajQxSDctOGl5c0ZtYm9fbnZ6aEU?oc=5","date":"2026-04-03","type":"earnings","source":"openPR.com","summary":"Open Angle Glaucoma Market: Expanding Revenue Landscape to 2034 - openPR.com","headline":"Open Angle Glaucoma Market: Expanding Revenue Landscape to 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxOcTFsdWh2ejBfaDNLQ1RrdmxPUTFpVkxaUXhLRHB0SDJBc2R5ZkUyaTNhMWp3OGJJZVB5b3pheUhVNTFqVVl5TVVlZml5Rk5qSHBMelVxV1BORjVySEJrYkxPRVk4SU1QaC1sNno2M2JoU0R5UXFyTDFCcWtTa0F5RF90aXZqeDNOT2dudWVGbkoweEdaZnpsYmRNeGl1aVJSR1ZHczJ4TlphWkRlcU1DbEU0V1RjWHBDQmVoaF9zRzdSZXc4S0RWQXozRkVmNEY0U2Q0eUIybWs4TmZrMnAxbFdocDAyNkZYRjQxejN0SEVqVGlZUXVVbFlLUHZoSG9OTUE?oc=5","date":"2023-05-18","type":"trial","source":"PR Newswire","summary":"Glaucoma Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Developing Drugs for the Market Entry - PR Newswire","headline":"Glaucoma Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Developing Drugs for the Market Entry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBmZTVVUnNzc0FETks5aWZFUU1jWmpiUElmUlNPanozYmZ2SHJ4Qm1ERkZDcDRHcGxrQzJYVHlxSlExWFA3N2lpNE1mWkduOVAtLVl2amNoczNIYms1cG41RDVaVTU2M2ljWGRhWlJFUnQ?oc=5","date":"2022-02-11","type":"pipeline","source":"EyeWorld","summary":"EyeWorld Weekly, February 11, 2022 - EyeWorld","headline":"EyeWorld Weekly, February 11, 2022","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}